Magenta Therapeutics, Inc

(NASDAQ:MGTA)

Latest On Magenta Therapeutics, Inc (MGTA):

Date/Time Type Description Signal Details
2023-05-03 13:01 ESTNewsMagenta Therapeutics to merge with Dianthus in all-stock dealN/A
2023-03-31 23:09 ESTNewsMagenta adopts stockholder rights plan to ward off unwanted bidsN/A
2023-02-02 21:13 ESTNewsMagenta Therapeutics up 47% on plan to pursue strategic alternativesN/A
2023-01-26 22:41 ESTNewsMagenta cut to Neutral at Wedbush as leukemia trial comes to a haltN/A
2023-01-25 19:22 ESTNewsMagenta Therapeutics pauses leukemia trial following participant death; down 25%N/A
2022-12-20 15:02 ESTNewsMagenta Therapeutics down 50% on acute myeloid leukemia dose escalation trialN/A
2022-12-13 08:52 ESTNewsMagenta Therapeutics soars 37% on data for acute myeloid leukemia candidateN/A
2022-11-03 12:10 ESTNewsMagenta Therapeutics GAAP EPS of -$0.27 beats by $0.03N/A
2022-08-25 15:21 ESTNewsMagenta Therapeutics downgraded to neutral at Goldman Sachs on clarity over candidateN/A
2022-08-04 13:47 ESTNewsMagenta Therapeutics GAAP EPS of -$0.29 beats by $0.06N/A
2022-05-16 15:12 ESTNewsMagenta Therapeutics GAAP EPS of -$0.39N/A
2022-04-14 10:10 ESTNewsMagenta Therapeutics prioritizes operational spending on MGTA-117 program, cuts workforceN/A
2022-01-29 03:25 ESTNewsMagenta Therapeutics (MGTA) Presents At J.P. Morgan Healthcare ConferenceN/A
2022-01-06 15:15 ESTNewsMagenta rises 6% on Goldman Sachs upgrade with $8 target priceN/A
2021-11-04 12:37 ESTNewsMagenta Therapeutics EPS beats by $0.03N/A
2021-09-22 00:20 ESTNewsMagenta wins FDA clearance to start conditioning clinical trial for MGTA-117N/A
2021-08-06 06:44 ESTNewsMagenta Therapeutics EPS beats by $0.05N/A
2021-07-21 15:32 ESTNewsBullish on AstraZeneca cancer drug, Cronos MSO stake not a big deal, and more in analyst actionN/A
2021-07-21 15:31 ESTNewsAfter recent weakness, gene therapy space offers a compelling opportunity: BTIGN/A
2021-07-21 15:28 ESTNewsMagenta Therapeutics (MGTA) EHA Investor Presentations - SlideshowN/A
2021-07-21 15:21 ESTNewsMagenta Therapeutics names Caren Deardorf as chief commercial officerN/A
2021-07-21 15:08 ESTNewsFDA puts Magenta's early-stage MGTA-117 leukemia trial on clinical holdN/A
2021-07-21 15:08 ESTNewsMagenta Therapeutics defended at Wedbush despite setback in blood cancer trialN/A
2021-05-06 15:29 ESTNewsMagenta Therapeutics EPS beats by $0.04N/A
2021-04-19 13:31 ESTNewsMagenta Therapeutics names David Nichols as chief technical officerN/A
2021-03-16 21:23 ESTAnalyst RatingThe Analyst Target Price has increased from $17 to $18.33.Buy
2021-03-04 12:05 ESTEarnings EstimateAn EPS average of -$1.84 is estimated for the 2022 year.Sell
2021-03-04 12:05 ESTEarnings EstimateAn EPS average of -$0.42 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-04 12:05 ESTAnalyst RatingThe Analyst Target Price has increased from $16.5 to $17.Buy
2021-03-04 04:07 ESTFinancialsCompany financials have been released.Neutral
2021-03-03 10:08 ESTNewsMagenta Therapeutics EPS beats by $0.02N/A
2021-01-20 05:26 ESTNewsMagenta Therapeutics (MGTA) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2021-01-11 20:18 ESTNewsMagenta Therapeutics announces expected 2021 highlights milestonesN/A
2021-01-08 08:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $16.67 to $16.5.Neutral
2021-01-06 16:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 20:48 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 00:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 08:22 ESTEarnings EstimateAn EPS average of -$0.45 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-05 09:17 ESTNewsMagenta Therapeutics EPS beats by $0.08N/A
2020-10-30 13:48 ESTAnalyst RatingThe Analyst Target Price has decreased from $18.5 to $16.67.Neutral
2020-09-26 13:23 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:29 ESTFinancialsCompany financials have been released.Neutral
2020-09-02 19:57 ESTNewsMagenta Therapeutics beefs up executive teamN/A
2020-09-02 19:57 ESTNewsMagenta nabs NIH grant to fund HIV cure researchN/A
2020-08-31 09:05 ESTNewsThe Low Down On Magenta TherapeuticsN/A
2020-08-19 05:11 ESTAnalyst RatingThe Analyst Target Price has increased from $17.33 to $18.5.Buy
2020-08-14 09:26 ESTFinancialsCompany financials have been released.Neutral
2020-08-08 09:11 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 21:42 ESTNewsMagenta Therapeutics EPS beats by $0.06N/A

About Magenta Therapeutics, Inc (MGTA):

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops novel medicines to bring the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy to patients. The company is developing C100 and C300 targeted antibody-drug conjugates for transplant conditioning; MGTA-145, a stem cell mobilization product candidate to control stem cell mobilization; MGTA-456, an allogeneic stem cell therapy to control stem cell growth; E478, a small molecule aryl hydrocarbon receptor antagonist for the expansion of gene-modified stem cells; and G100, an antibody-drug conjugate program to prevent prophylaxis of graft-versus-host diseases. It has a has a research and clinical collaboration agreement with AVROBIO, Inc.to evaluate potential utility of MGTA-117 for conditioning of patients receiving one or more investigational lentiviral gene therapies; and clinical trial collaboration with bluebird bio, Inc. to evaluate the utility of MGTA-145, in combination with plerixafor, for mobilization and collection of stem cells in adults and adolescents with sickle cell disease. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

MGTA Quotes by TradingView

See Advanced Chart

General

  • Name Magenta Therapeutics, Inc
  • Symbol MGTA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 69
  • Fiscal Year EndDecember
  • IPO Date2018-06-21
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.magentatx.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 4.24
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.67
  • Next Year EPS Estimate -$1.71
  • Next Quarter EPS Estimate -$0.42
  • Return on Assets -30%
  • Return on Equity -53%
  • Earnings Per Share -$1.91
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 597.73 million
  • EBITDA -68877000
  • Analyst Target Price $18.33
  • Book Value Per Share $2.97
View More

Share Statistics

  • Shares Outstanding 48.56 million
  • Shares Float 30.22 million
  • % Held by Insiders 1179%
  • % Held by Institutions 70.71%
  • Shares Short 1.73 million
  • Shares Short Prior Month 1.67 million
  • Short Ratio 4.23
  • Short % of Float 6%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 2.42
  • 52 Week High $13.69
  • 52 Week Low $5.76
  • 50 Day Moving Average 10.95
  • 200 Day Moving Average 8.24
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Magenta Therapeutics, Inc (MGTA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Magenta Therapeutics, Inc (MGTA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-03$N/A-$0.37-$0.407.59%
2020-09-302020-11-05$N/A-$0.37-$0.4517.7%
2020-06-302020-08-06$N/A-$0.48-$0.5410.7%
2020-03-312020-05-07$N/A-$0.51-$0.6318.43%
2019-12-312020-03-03$N/A-$0.60-$0.59-1.32%
2019-09-302019-11-13$N/A-$0.54-$0.540.24%
2019-06-302019-08-08$N/A-$0.48-$0.538.94%
2019-03-312019-05-09$N/A-$0.44-$0.5723.26%
2018-12-312019-03-19$N/A-$0.50-$0.569.93%
2018-09-302018-11-08$N/A-$0.49-$0.46-7.15%
2018-06-302018-08-09$N/A-$0.42-$0.8852.52%

Magenta Therapeutics, Inc (MGTA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 12.26 million N/A N/A N/A 18.71 million
Income Before Tax -18.17 million N/A N/A N/A -23.24 million
Selling General Administrative 6.81 million N/A N/A N/A 5.92 million
Gross Profit N/A N/A N/A N/A N/A
Ebit -18.17 million N/A N/A N/A -24.64 million
Operating Income -19.07 million N/A N/A N/A -24.64 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A N/A 1.4 million
Net Income From Continuing Operations -18.17 million N/A N/A N/A -23.24 million
Net Income Applicable to Common Shares -18.17 million -17.68 million -19.08 million -20.01 million -23.24 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A -5.57 million 64.34 million
Change to Liabilities -185000 -1.37 million 1.14 million 774000 -199000
Total Cash Flow from Investing Activities 19.98 million 14.96 million 25.4 million -5.72 million 63.81 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A 914000 95000
Change to Operating Activities 525000 -1.8 million -1.03 million 4.39 million 6.73 million
Change in Cash N/A N/A N/A -20.44 million 52.4 million
Total Cash from Operating Activities -14.43 million -19.21 million -16.66 million -15.63 million -11.51 million
Depreciation N/A N/A N/A 485000 483000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities -237000 N/A N/A N/A -162000
Change to Net Income 2.42 million 2.55 million 2.75 million 1.96 million 2.47 million
Capital Expenditures N/A N/A N/A 153000 530000
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 17.71 million N/A N/A N/A 20.32 million
Total Stockholder Equity 143.91 million N/A N/A N/A 141.19 million
Other Current Liabilities N/A N/A N/A N/A 619000
Total Assets 161.62 million N/A N/A N/A 161.51 million
Common Stock 49000 48000 48000 39000 39000
Other Current Assets 2.69 million N/A N/A N/A N/A
Retained Earnings -254.43 million -236.26 million -218.59 million -199.51 million -179.5 million
Other Liabilities N/A 6.21 million 6.44 million 6.34 million 6.21 million
Other Assets N/A 1.78 million 1.78 million 1.78 million 1.78 million
Cash 58.15 million N/A N/A N/A 65.07 million
Total Current Liabilities 11.43 million 9.86 million N/A N/A 14.12 million
Other Stockholder Equity -23000 39000 153000 363000 8000
Property, Plant & Equipment 8.31 million 8.59 million 9.07 million 9.53 million 9.89 million
Total Current Assets 151.53 million 164.27 million N/A N/A 149.84 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 143.91 million 158.57 million 173.91 million 125.4 million 141.19 million
Short Term Investments 90.68 million N/A N/A N/A 80.66 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 11.43 million 2.39 million N/A N/A 2.81 million

Magenta Therapeutics, Inc (MGTA) Chart:

Magenta Therapeutics, Inc (MGTA) News:

Below you will find a list of latest news for Magenta Therapeutics, Inc (MGTA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Magenta Therapeutics, Inc (MGTA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest MGTA Trades:

Date Shares Price
Jun 13, 2022 7:56 PM EST100$1.305
Jun 13, 2022 7:56 PM EST16$1.305
Jun 13, 2022 7:57 PM EST100$1.31
Jun 13, 2022 7:57 PM EST100$1.31
Jun 13, 2022 7:59 PM EST100$1.285

Magenta Therapeutics, Inc (MGTA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000120919120039768/0001209191-20-039768-index.htm
2019-04-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1690585/000000000019006551/0000000000-19-006551-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1690585/000000000019012296/0000000000-19-012296-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924318018332/0000899243-18-018332-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924318018333/0000899243-18-018333-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924318018334/0000899243-18-018334-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924318018338/0000899243-18-018338-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924318018339/0000899243-18-018339-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924318018341/0000899243-18-018341-index.htm
2018-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924318018342/0000899243-18-018342-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924318025421/0000899243-18-025421-index.htm
2019-01-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319000524/0000899243-19-000524-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319000527/0000899243-19-000527-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319000529/0000899243-19-000529-index.htm
2019-02-073/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319002863/0000899243-19-002863-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319002865/0000899243-19-002865-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319002869/0000899243-19-002869-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319002870/0000899243-19-002870-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319002872/0000899243-19-002872-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319002874/0000899243-19-002874-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319016406/0000899243-19-016406-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319016407/0000899243-19-016407-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319016410/0000899243-19-016410-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319016413/0000899243-19-016413-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319016414/0000899243-19-016414-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319016419/0000899243-19-016419-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319016421/0000899243-19-016421-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319016422/0000899243-19-016422-index.htm
2019-06-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319017952/0000899243-19-017952-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924319017955/0000899243-19-017955-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320004301/0000899243-20-004301-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320004308/0000899243-20-004308-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320004313/0000899243-20-004313-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320004316/0000899243-20-004316-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320004321/0000899243-20-004321-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320004667/0000899243-20-004667-index.htm
2020-03-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320007784/0000899243-20-007784-index.htm
2020-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320010847/0000899243-20-010847-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320015789/0000899243-20-015789-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320015790/0000899243-20-015790-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320015796/0000899243-20-015796-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320015797/0000899243-20-015797-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320015798/0000899243-20-015798-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320015799/0000899243-20-015799-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320015801/0000899243-20-015801-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320015805/0000899243-20-015805-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320015808/0000899243-20-015808-index.htm
2020-09-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320025328/0000899243-20-025328-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320025332/0000899243-20-025332-index.htm
2020-10-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320028077/0000899243-20-028077-index.htm
2020-11-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320030391/0000899243-20-030391-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000089924320030392/0000899243-20-030392-index.htm
2018-07-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000091957418004468/0000919574-18-004468-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000091957419001619/0000919574-19-001619-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000091957420000802/0000919574-20-000802-index.htm
2019-03-29DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1690585/000095012319002947/0000950123-19-002947-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000110465920020275/0001104659-20-020275-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000110465920021008/0001104659-20-021008-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000114420419007203/0001144204-19-007203-index.htm
2019-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000114420419030464/0001144204-19-030464-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312518244347/0001193125-18-244347-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1690585/000119312518244360/0001193125-18-244360-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312518321948/0001193125-18-321948-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1690585/000119312518321954/0001193125-18-321954-index.htm
2018-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312518330256/0001193125-18-330256-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312519003130/0001193125-19-003130-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312519015933/0001193125-19-015933-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000119312519034462/0001193125-19-034462-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000119312519037919/0001193125-19-037919-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312519078945/0001193125-19-078945-index.htm
2019-03-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1690585/000119312519078948/0001193125-19-078948-index.htm
2019-03-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1690585/000119312519078954/0001193125-19-078954-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1690585/000119312519119735/0001193125-19-119735-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1690585/000119312519119744/0001193125-19-119744-index.htm
2019-04-29S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1690585/000119312519125154/0001193125-19-125154-index.htm
2019-04-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1690585/000119312519125338/0001193125-19-125338-index.htm
2019-04-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1690585/000119312519125363/0001193125-19-125363-index.htm
2019-05-02424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1690585/000119312519135014/0001193125-19-135014-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312519138390/0001193125-19-138390-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312519142288/0001193125-19-142288-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1690585/000119312519142296/0001193125-19-142296-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312519170256/0001193125-19-170256-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312519180195/0001193125-19-180195-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312519216099/0001193125-19-216099-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1690585/000119312519216106/0001193125-19-216106-index.htm
2019-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1690585/000119312519216838/0001193125-19-216838-index.htm
2019-08-08S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1690585/000119312519216847/0001193125-19-216847-index.htm
2019-08-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1690585/000119312519221210/0001193125-19-221210-index.htm
2019-08-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1690585/000119312519226073/0001193125-19-226073-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312519290573/0001193125-19-290573-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1690585/000119312519290577/0001193125-19-290577-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520005958/0001193125-20-005958-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520059812/0001193125-20-059812-index.htm
2020-03-0310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1690585/000119312520059835/0001193125-20-059835-index.htm
2020-03-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1690585/000119312520059839/0001193125-20-059839-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520109392/0001193125-20-109392-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520110697/0001193125-20-110697-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1690585/000119312520118192/0001193125-20-118192-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1690585/000119312520118194/0001193125-20-118194-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520135611/0001193125-20-135611-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1690585/000119312520135615/0001193125-20-135615-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520164669/0001193125-20-164669-index.htm
2020-06-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1690585/000119312520177793/0001193125-20-177793-index.htm
2020-06-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1690585/000119312520179170/0001193125-20-179170-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520183374/0001193125-20-183374-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520183376/0001193125-20-183376-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520211372/0001193125-20-211372-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1690585/000119312520211380/0001193125-20-211380-index.htm
2020-09-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520238147/0001193125-20-238147-index.htm
2020-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520262538/0001193125-20-262538-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1690585/000119312520286280/0001193125-20-286280-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1690585/000119312520286283/0001193125-20-286283-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000120919119021014/0001209191-19-021014-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000120919119021017/0001209191-19-021017-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000120919120039768/0001209191-20-039768-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000120919120042320/0001209191-20-042320-index.htm
2020-07-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1690585/000138713120006396/0001387131-20-006396-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019003585/0001562180-19-003585-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019003623/0001562180-19-003623-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019003624/0001562180-19-003624-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019003734/0001562180-19-003734-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019004122/0001562180-19-004122-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019004630/0001562180-19-004630-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019004830/0001562180-19-004830-index.htm
2019-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019004884/0001562180-19-004884-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019005101/0001562180-19-005101-index.htm
2019-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019005307/0001562180-19-005307-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019005711/0001562180-19-005711-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019005782/0001562180-19-005782-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006009/0001562180-19-006009-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006078/0001562180-19-006078-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006220/0001562180-19-006220-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006221/0001562180-19-006221-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006252/0001562180-19-006252-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006260/0001562180-19-006260-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006261/0001562180-19-006261-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006265/0001562180-19-006265-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006266/0001562180-19-006266-index.htm
2019-12-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218019006291/0001562180-19-006291-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218020000118/0001562180-20-000118-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218020000119/0001562180-20-000119-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1690585/000156218020000327/0001562180-20-000327-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000158064219000778/0001580642-19-000778-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1690585/000158064220000515/0001580642-20-000515-index.htm
2019-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1690585/999999999519000986/9999999995-19-000986-index.htm
2019-08-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1690585/999999999519001923/9999999995-19-001923-index.htm
2019-04-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1690585/999999999719002757/9999999997-19-002757-index.htm
2019-09-10CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1690585/999999999719006734/9999999997-19-006734-index.htm

Magenta Therapeutics, Inc (MGTA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Magenta Therapeutics, Inc (MGTA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1179%
Institutional Ownership: 7071%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-20Atlas Venture Fund X, L.P.10% Share HolderSell14,245.0017.86254,415.700.00https://www.sec.gov/Archives/edgar/data/1690585/000120919119021017/0001209191-19-021017-index.htm
2019-03-20Bruce BoothDirectorSell14,245.0017.86254,415.700.00https://www.sec.gov/Archives/edgar/data/1690585/000120919119021014/0001209191-19-021014-index.htm
2020-06-29Bruce BoothDirectorBuy1,250,000.008.0010,000,000.001,250,000.00https://www.sec.gov/Archives/edgar/data/1690585/000120919120039768/0001209191-20-039768-index.htm
2019-12-24ZORAN ZDRAVESKIOfficerSell7,902.0016.00126,432.00128,009.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006265/0001562180-19-006265-index.htm
2019-12-09JOHN C. JR DAVISChief Medical OfficerBuy4,614.009.4943,786.8612,918.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006009/0001562180-19-006009-index.htm
2019-12-23ZORAN ZDRAVESKIOfficerSell4,181.0016.0367,021.43135,911.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006261/0001562180-19-006261-index.htm
2020-01-02JOHN C. JR DAVISChief Medical OfficerBuy11,294.009.49107,180.0619,598.00https://www.sec.gov/Archives/edgar/data/1690585/000156218020000119/0001562180-20-000119-index.htm
2018-06-25David ScaddenDirectorBuy6,600.0015.0099,000.00228,175.00https://www.sec.gov/Archives/edgar/data/1690585/000089924318018341/0000899243-18-018341-index.htm
2019-12-02MICHAEL P. COOKEChief Scientific OfficerSell2,500.0013.2133,036.00240,523.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019005782/0001562180-19-005782-index.htm
2019-12-02MICHAEL P. COOKEChief Scientific OfficerSell1,373.0013.3118,279.30243,023.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019005782/0001562180-19-005782-index.htm
2019-12-02MICHAEL P. COOKEChief Scientific OfficerSell3,627.0012.7446,204.72244,396.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019005782/0001562180-19-005782-index.htm
2019-11-20MICHAEL P. COOKEChief Scientific OfficerSell5,000.0012.0060,000.00248,023.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019005711/0001562180-19-005711-index.htm
2020-01-10JASON GARDNEROfficerSell11,200.0015.25170,800.00251,212.00https://www.sec.gov/Archives/edgar/data/1690585/000156218020000327/0001562180-20-000327-index.htm
2019-11-01MICHAEL P. COOKEChief Scientific OfficerSell5,000.0010.6753,333.50253,023.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019005307/0001562180-19-005307-index.htm
2019-12-10JOHN C. JR DAVISChief Medical OfficerBuy17,055.009.49161,851.9525,359.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006009/0001562180-19-006009-index.htm
2019-10-01MICHAEL P. COOKEChief Scientific OfficerSell5,000.0010.0150,064.00258,023.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019005101/0001562180-19-005101-index.htm
2020-01-02JASON GARDNEROfficerSell2,800.0015.1042,280.00262,412.00https://www.sec.gov/Archives/edgar/data/1690585/000156218020000118/0001562180-20-000118-index.htm
2019-09-19MICHAEL P. COOKEChief Scientific OfficerSell1,656.0012.0019,872.00263,023.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019004884/0001562180-19-004884-index.htm
2019-09-12MICHAEL P. COOKEChief Scientific OfficerSell844.0012.0010,128.00264,679.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019004830/0001562180-19-004830-index.htm
2019-12-23JASON GARDNEROfficerSell2,897.0015.1043,754.55265,212.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006252/0001562180-19-006252-index.htm
2019-09-03MICHAEL P. COOKEChief Scientific OfficerSell5,000.0010.1150,531.00265,523.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019004630/0001562180-19-004630-index.htm
2019-12-20JASON GARDNEROfficerSell76,711.0015.161,162,616.57268,109.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006221/0001562180-19-006221-index.htm
2019-08-01MICHAEL P. COOKEChief Scientific OfficerSell2,500.0013.4133,522.50270,523.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019004122/0001562180-19-004122-index.htm
2019-08-01MICHAEL P. COOKEChief Scientific OfficerSell5,000.0013.4267,108.50273,023.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019004122/0001562180-19-004122-index.htm
2019-07-01MICHAEL P. COOKEChief Scientific OfficerSell2,500.0014.4236,050.50278,023.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019003734/0001562180-19-003734-index.htm
2019-07-01MICHAEL P. COOKEChief Scientific OfficerSell5,000.0014.3971,932.50280,523.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019003734/0001562180-19-003734-index.htm
2019-06-17MICHAEL P. COOKEChief Scientific OfficerSell7,500.0013.90104,267.25285,523.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019003585/0001562180-19-003585-index.htm
2019-12-10JASON GARDNEROfficerSell4,392.0015.1066,319.20344,820.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006078/0001562180-19-006078-index.htm
2019-06-21JASON GARDNEROfficerSell12,331.0015.11186,321.41349,212.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019003623/0001562180-19-003623-index.htm
2019-06-20JASON GARDNEROfficerSell1,669.0015.1025,201.90361,543.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019003623/0001562180-19-003623-index.htm
2019-12-09JOHN C. JR DAVISChief Medical OfficerSell4,614.0015.0069,210.008,304.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006009/0001562180-19-006009-index.htm
2019-12-10JOHN C. JR DAVISChief Medical OfficerSell17,055.0015.00255,825.008,304.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006009/0001562180-19-006009-index.htm
2019-12-20JOHN C. JR DAVISChief Medical OfficerSell919.0015.0013,785.008,304.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006220/0001562180-19-006220-index.htm
2020-01-02JOHN C. JR DAVISChief Medical OfficerSell11,294.0015.04169,816.588,304.00https://www.sec.gov/Archives/edgar/data/1690585/000156218020000119/0001562180-20-000119-index.htm
2019-12-24CHRISTINA K. ISACSONChief Business OfficerSell4,463.0016.0171,452.6383,786.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006266/0001562180-19-006266-index.htm
2019-12-20JOHN C. JR DAVISChief Medical OfficerBuy114.009.491,081.868,418.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006220/0001562180-19-006220-index.htm
2019-12-23CHRISTINA K. ISACSONChief Business OfficerSell9,867.0016.03158,168.0188,249.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006260/0001562180-19-006260-index.htm
2019-12-20JOHN C. JR DAVISChief Medical OfficerBuy805.009.497,639.459,223.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019006220/0001562180-19-006220-index.htm
2019-06-21CHRISTINA K. ISACSONChief Business OfficerSell5,415.0016.0787,019.0598,116.00https://www.sec.gov/Archives/edgar/data/1690585/000156218019003624/0001562180-19-003624-index.htm